| abstract |
The following compounds of the formula (I) are described herein, for example: (1) wherein R1, R2, R3 and R4 are as described herein, which are useful as inhibitors of plasma carboxypeptidase B. Pharmaceutical compositions containing these compounds, the methods for using these compounds as antithrombotic agents and the processes for synthesizing these compounds are also described herein. |